Author

Annette T. Byrne

Royal College of Surgeons in IrelandORCID 0000-0003-0287-8899Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:human· 3 Research Focus:differential expression· 2 Assay:scRNA-seq· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Approach:deep learning· 1

Frequent Co-Authors

Alice C. O’FarrelliD· 2 shared Diether LambrechtsiD· 2 shared Jochen H.M. PrehniD· 2 shared Abhishek Dinkarnath GargiD· 1 shared Ahmed IdbaïhiD· 1 shared Aidan D. MeadeiD· 1 shared Alison Dooney· 1 shared Andreas KremeriD· 1 shared

Activity by Year

2023-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Alice C. O’FarrellORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioinformaticsPLoS Computational BiologyPeer-reviewedMay 26, 2026

DREAMER-S: Deep leaRning-Enabled Attention-based Multiple-instance approaches with Explainable Representations for Spatial Biology

Mohd Rifqi Rafsanjani, Alison Dooney, Rahul Suresh…·Aidan D. Meade

DREAMER-S uses attention-based multiple-instance learning to identify spatial features in 3D imaging data for classification, achieving high F1 scores in chemotherapy response prediction.

DOI 10.1371/journal.pcbi.1013581

humanspatial transcriptomics

𝕏 PostBluesky

Cancer BiologyNeuro-OncologyPeer-reviewedJan 27, 2026

Distinct tumor immune microenvironmental (TIME) landscapes drive divergent immunotherapy responses in glioblastoma

Linqian Weng, Krish Skandha Gopalan, Mélanie Guyot…·Gabriele Bergers

This study identifies three distinct tumor immune microenvironment (TIME) subtypes in glioblastoma (GBM) with divergent responses to immunotherapy, supporting personalized treatment strategies.

4 citationstop 1%

humanmouse

𝕏 PostBluesky

Cancer BiologyInternational Journal of Molecular SciencesPeer-reviewedOct 27, 2023

Identification of inter- and intra-tumoral molecular phenotypes steering temozolomide resistance in patient-derived glioblastoma cells.

Federica Fabro, Trisha V. Kers, Kate J. Feller…·Sieger Leenstra

This study identifies two molecular phenotypes, ADA and N-ADA, associated with temozolomide resistance in glioblastoma cells through bulk and single-cell RNA sequencing.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky